Silicon Laboratories Inc. — Form 10-Q Summary
Period clarification: The supplied filing is for the first quarter of fiscal 2024, ended March 30, 2024, compared with the quarter ended April 1, 2023. This does not match the request metadata’s “2023 Q1.”
Business context and reporting period
Silicon Labs develops mixed-signal semiconductor products and wireless technology for IoT applications. It reports revenue in Industrial & Commercial and Home & Life product groups. The company is fabless and depends on third parties, principally in Asia, for wafer fabrication, assembly and testing. Management attributed weak demand to customers reducing inventories amid a softening market and macroeconomic uncertainty.
Financial results and liquidity
| Metric | Q1 FY2024 | Q1 FY2023 |
|---|---|---|
| Revenue | $106.4 million | $246.8 million |
| Gross profit / margin | $55.1 million / 51.8% | $153.9 million / 62.3% |
| Operating income (loss) | $(59.1) million | $19.6 million |
| Net income (loss) | $(56.5) million | $14.0 million |
| Diluted EPS | $(1.77) | $0.41 |
| Net cash used in operating activities | $(71.8) million | $(13.3) million |
- Revenue fell 56.9%. Industrial & Commercial revenue declined 56.7% to $65.3 million; Home & Life declined 57.2% to $41.1 million. Management cited lower unit volumes and average selling prices.
- Gross margin decreased 10.5 percentage points year over year, primarily due to customer and product mix. Operating expenses fell to $114.2 million from $134.3 million, mainly reflecting lower personnel costs after the Q4 2023 workforce reduction; expenses nevertheless exceeded revenue.
- At March 30, 2024, cash and cash equivalents were $191.5 million and short-term investments were $141.2 million, totaling $332.7 million. Cash and investments held by U.S. entities were $191.7 million.
- Operating cash outflow included the net loss and a $36.3 million net cash outflow from changes in operating assets and liabilities. Investing activities provided $81.5 million, including proceeds from marketable-security activity and a $12.4 million equity-investment sale. Financing activities used $45.7 million, including repayment of $45.0 million of credit-facility borrowings.
- Inventory was $198.2 million, or 348 days of inventory, versus $194.3 million and 407 days at fiscal year-end. Receivables were $32.6 million; DSO was 28 days.
- No revolving-credit borrowings remained outstanding at quarter-end under the $400 million facility, which matures in 2028. The company reported compliance with its covenants. Total liabilities were $178.6 million and stockholders’ equity was $1.166 billion.
Material changes versus the prior comparable period
- The company moved from operating and net profit to substantial operating and net losses, principally as revenue and gross profit contracted sharply.
- Revenue from distributors was $70.4 million, down from $204.9 million; direct-customer revenue was $36.0 million, down from $41.9 million.
- Operating cash use increased to $71.8 million from $13.3 million. The quarter-end cash and investment balance was lower than at fiscal year-end, while the company repaid its $45.0 million revolving-facility balance.
- Interest expense declined to $0.5 million from $1.7 million, primarily following settlement of the 2025 convertible notes in Q2 2023.
Outlook, commentary and risks
- Q2 FY2024 outlook: Revenue of $135–$145 million, gross margin of 53%, operating expenses of approximately $125 million, and diluted loss per share of $(1.61) to $(1.45). Management expected R&D and SG&A to increase in absolute dollars in Q2.
- Management said customers were reducing inventory and were more frequently requesting order cancellations, delivery-date changes, and price or payment-term concessions. It cited inflation, high interest rates, geopolitical tensions and a weak demand environment. Results may fluctuate and the quarter is not necessarily indicative of full-year performance.
- A workforce reduction of approximately 10% was implemented in Q4 2023. The company recorded $0.5 million of restructuring charges in Q1 2024; $3.9 million remained in the restructuring liability at quarter-end.
- Internal controls: A previously identified material weakness in inventory valuation remained unremediated. Management concluded disclosure controls and procedures were not effective at March 30, 2024. Remediation work was ongoing, with completion anticipated by year-end 2024, although timing is not assured.
- Tax contingency: A Norwegian tax assessment relating to 2013 intercompany pricing could require approximately 141.3 million Norwegian kroner, or $13.0 million, of additional tax. The company is appealing, believes its position is more likely than not to be sustained, and says it has accrued adequate reserves; an unfavorable outcome could materially affect the financial statements.
- Other significant risks include semiconductor cyclicality and pricing pressure; customer and distributor inventory and order volatility; reliance on concentrated third-party manufacturing and assembly capacity, particularly in Asia; geopolitical and supply-chain disruption; and cybersecurity, product, competition and intellectual-property risks. Two distributors each accounted for more than 10% of revenue; distributors represented 66% of revenue overall and the two largest 43%. Revenue outside the U.S. was 95%.
- The company said existing cash, investments and operating cash generation should cover short- and long-term capital requirements, but noted funding needs could change. A 100-basis-point decline in investment yields would reduce annual interest income by approximately $2.5 million.
Important facts for investors to verify
- Confirm the intended reporting period: the filing covers Q1 FY2024, not Q1 2023.
- Track whether revenue, unit demand, selling prices and gross margin improve against the Q2 outlook, and whether inventory levels continue to normalize.
- Monitor cash burn, liquidity and covenant compliance, including the effects of further operating losses.
- Assess progress and testing of the inventory-valuation control remediation, and whether the material weakness is resolved by the stated target.
- Follow the Norwegian tax appeal and any change in the company’s reserve or assessment of potential exposure.
- Evaluate dependence on distributors and Asia-based suppliers, alongside the impact of customer order changes and geopolitical or supply-chain disruption.